Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion
To develop French recommendations about screening and management of cardiovascular risk factors in systemic lupus erythematosus (SLE). Thirty-nine experts qualified in internal medicine, rheumatology and nephrology have selected recommendations from a list developed based on evidence from the litera...
Gespeichert in:
| Veröffentlicht in: | La revue de medecine interne 2015-06, Vol.36 (6), p.372 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 372 |
| container_title | La revue de medecine interne |
| container_volume | 36 |
| creator | Arnaud, L Mathian, A Adoue, D Bader-Meunier, B Baudouin, V Belizna, C Bonnotte, B Boumedine, F Chaib, A Chauchard, M Chiche, L Daugas, E Ghali, A Gobert, P Gondran, G Guettrot-Imbert, G Hachulla, E Hamidou, M Haroche, J Hervier, B Hummel, A Jourde-Chiche, N Korganow, A-S Kwon, T Le Guern, V Le Quellec, A Limal, N Magy-Bertrand, N Marianetti-Guingel, P Martin, T Martin Silva, N Meyer, O Miyara, M Morell-Dubois, S Ninet, J Papo, T Pennaforte, J-L Polomat, K Pourrat, J Queyrel, V Raymond, I Remy, P Sacre, K Schmidt, J Sibilia, J Viallard, J-F Viau Brabant, A Wahl, D Bruckert, E Amoura, Z |
| description | To develop French recommendations about screening and management of cardiovascular risk factors in systemic lupus erythematosus (SLE).
Thirty-nine experts qualified in internal medicine, rheumatology and nephrology have selected recommendations from a list developed based on evidence from the literature. For each recommendation, the level of evidence and the level of agreement among the experts were specified.
Experts recommended an annual screening of cardiovascular risk factors in SLE. Statins should be prescribed for primary prevention in SLE patients based on the level of LDL-cholesterol and the number of cardiovascular risk factors, considering SLE as an additional risk factor. For secondary prevention, experts have agreed on an LDL-cholesterol target of |
| doi_str_mv | 10.1016/j.revmed.2014.10.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1683353569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1683353569</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-b8a4caf6768ebfc512bb74782298dbab83dec1797e0b17f8c6aa4413b83d3d043</originalsourceid><addsrcrecordid>eNpNUctOHDEQtKJEsCH8AUJ9zGU39tjz4oZWgURCQgpwXrU9PRvDjD3YnlX2k_jLOLCROHWru6pU1c3YmeArwUX17XEVaDdStyq4UHm04rz9wBairpqlFEXx8V1_zD7H-Mg5z8z2iB0XpSrLtlQL9nJnApGzbgvoOhjR4ZZGcgl8DwZDZ_0Oo5kHDBBsfIIeTfIhgnUQ9zHRaA0M8zRHoLBPv2nE5OMcL-AXGT9mpQ6T9S5C7wOYwTprcIApZBlrCDRG6sA7yFQYbKKAaQ70aob-TBSykSmTvPvCPvU4RDo91BP2cPX9fv1jeXN7_XN9ebOchBJpqRtUBvsqRyfdm1IUWteqboqibTqNupEdGVG3NXEt6r4xFaJSQv5byI4recK-vulOwT_PFNNmtNHQMKAjP8eNqBopS1lWbYaeH6Czzp_YTMGOGPab_-eVfwGbfoQY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1683353569</pqid></control><display><type>article</type><title>Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Arnaud, L ; Mathian, A ; Adoue, D ; Bader-Meunier, B ; Baudouin, V ; Belizna, C ; Bonnotte, B ; Boumedine, F ; Chaib, A ; Chauchard, M ; Chiche, L ; Daugas, E ; Ghali, A ; Gobert, P ; Gondran, G ; Guettrot-Imbert, G ; Hachulla, E ; Hamidou, M ; Haroche, J ; Hervier, B ; Hummel, A ; Jourde-Chiche, N ; Korganow, A-S ; Kwon, T ; Le Guern, V ; Le Quellec, A ; Limal, N ; Magy-Bertrand, N ; Marianetti-Guingel, P ; Martin, T ; Martin Silva, N ; Meyer, O ; Miyara, M ; Morell-Dubois, S ; Ninet, J ; Papo, T ; Pennaforte, J-L ; Polomat, K ; Pourrat, J ; Queyrel, V ; Raymond, I ; Remy, P ; Sacre, K ; Schmidt, J ; Sibilia, J ; Viallard, J-F ; Viau Brabant, A ; Wahl, D ; Bruckert, E ; Amoura, Z</creator><creatorcontrib>Arnaud, L ; Mathian, A ; Adoue, D ; Bader-Meunier, B ; Baudouin, V ; Belizna, C ; Bonnotte, B ; Boumedine, F ; Chaib, A ; Chauchard, M ; Chiche, L ; Daugas, E ; Ghali, A ; Gobert, P ; Gondran, G ; Guettrot-Imbert, G ; Hachulla, E ; Hamidou, M ; Haroche, J ; Hervier, B ; Hummel, A ; Jourde-Chiche, N ; Korganow, A-S ; Kwon, T ; Le Guern, V ; Le Quellec, A ; Limal, N ; Magy-Bertrand, N ; Marianetti-Guingel, P ; Martin, T ; Martin Silva, N ; Meyer, O ; Miyara, M ; Morell-Dubois, S ; Ninet, J ; Papo, T ; Pennaforte, J-L ; Polomat, K ; Pourrat, J ; Queyrel, V ; Raymond, I ; Remy, P ; Sacre, K ; Schmidt, J ; Sibilia, J ; Viallard, J-F ; Viau Brabant, A ; Wahl, D ; Bruckert, E ; Amoura, Z ; groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides</creatorcontrib><description>To develop French recommendations about screening and management of cardiovascular risk factors in systemic lupus erythematosus (SLE).
Thirty-nine experts qualified in internal medicine, rheumatology and nephrology have selected recommendations from a list developed based on evidence from the literature. For each recommendation, the level of evidence and the level of agreement among the experts were specified.
Experts recommended an annual screening of cardiovascular risk factors in SLE. Statins should be prescribed for primary prevention in SLE patients based on the level of LDL-cholesterol and the number of cardiovascular risk factors, considering SLE as an additional risk factor. For secondary prevention, experts have agreed on an LDL-cholesterol target of <0.7 g/L. Hypertension should be managed according to the 2013 European guidelines, using renin-angiotensin system blockers as first line agents in case of renal involvement. Aspirin can be prescribed in patients with high cardiovascular risk or with antiphospholipid antibodies.
These recommendations about the screening and management of cardiovascular risk factors in SLE can be expected to improve clinical practice uniformity and, in the longer term, to optimize the management of SLE patients.</description><identifier>ISSN: 1768-3122</identifier><identifier>EISSN: 1768-3122</identifier><identifier>DOI: 10.1016/j.revmed.2014.10.009</identifier><identifier>PMID: 25455954</identifier><language>fre</language><publisher>France</publisher><subject>Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - etiology ; Evidence-Based Medicine ; Guidelines as Topic ; Humans ; Lupus Erythematosus, Systemic - complications ; Mass Screening - methods ; Risk Factors ; Secondary Prevention</subject><ispartof>La revue de medecine interne, 2015-06, Vol.36 (6), p.372</ispartof><rights>Copyright © 2014 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25455954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arnaud, L</creatorcontrib><creatorcontrib>Mathian, A</creatorcontrib><creatorcontrib>Adoue, D</creatorcontrib><creatorcontrib>Bader-Meunier, B</creatorcontrib><creatorcontrib>Baudouin, V</creatorcontrib><creatorcontrib>Belizna, C</creatorcontrib><creatorcontrib>Bonnotte, B</creatorcontrib><creatorcontrib>Boumedine, F</creatorcontrib><creatorcontrib>Chaib, A</creatorcontrib><creatorcontrib>Chauchard, M</creatorcontrib><creatorcontrib>Chiche, L</creatorcontrib><creatorcontrib>Daugas, E</creatorcontrib><creatorcontrib>Ghali, A</creatorcontrib><creatorcontrib>Gobert, P</creatorcontrib><creatorcontrib>Gondran, G</creatorcontrib><creatorcontrib>Guettrot-Imbert, G</creatorcontrib><creatorcontrib>Hachulla, E</creatorcontrib><creatorcontrib>Hamidou, M</creatorcontrib><creatorcontrib>Haroche, J</creatorcontrib><creatorcontrib>Hervier, B</creatorcontrib><creatorcontrib>Hummel, A</creatorcontrib><creatorcontrib>Jourde-Chiche, N</creatorcontrib><creatorcontrib>Korganow, A-S</creatorcontrib><creatorcontrib>Kwon, T</creatorcontrib><creatorcontrib>Le Guern, V</creatorcontrib><creatorcontrib>Le Quellec, A</creatorcontrib><creatorcontrib>Limal, N</creatorcontrib><creatorcontrib>Magy-Bertrand, N</creatorcontrib><creatorcontrib>Marianetti-Guingel, P</creatorcontrib><creatorcontrib>Martin, T</creatorcontrib><creatorcontrib>Martin Silva, N</creatorcontrib><creatorcontrib>Meyer, O</creatorcontrib><creatorcontrib>Miyara, M</creatorcontrib><creatorcontrib>Morell-Dubois, S</creatorcontrib><creatorcontrib>Ninet, J</creatorcontrib><creatorcontrib>Papo, T</creatorcontrib><creatorcontrib>Pennaforte, J-L</creatorcontrib><creatorcontrib>Polomat, K</creatorcontrib><creatorcontrib>Pourrat, J</creatorcontrib><creatorcontrib>Queyrel, V</creatorcontrib><creatorcontrib>Raymond, I</creatorcontrib><creatorcontrib>Remy, P</creatorcontrib><creatorcontrib>Sacre, K</creatorcontrib><creatorcontrib>Schmidt, J</creatorcontrib><creatorcontrib>Sibilia, J</creatorcontrib><creatorcontrib>Viallard, J-F</creatorcontrib><creatorcontrib>Viau Brabant, A</creatorcontrib><creatorcontrib>Wahl, D</creatorcontrib><creatorcontrib>Bruckert, E</creatorcontrib><creatorcontrib>Amoura, Z</creatorcontrib><creatorcontrib>groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides</creatorcontrib><title>Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>To develop French recommendations about screening and management of cardiovascular risk factors in systemic lupus erythematosus (SLE).
Thirty-nine experts qualified in internal medicine, rheumatology and nephrology have selected recommendations from a list developed based on evidence from the literature. For each recommendation, the level of evidence and the level of agreement among the experts were specified.
Experts recommended an annual screening of cardiovascular risk factors in SLE. Statins should be prescribed for primary prevention in SLE patients based on the level of LDL-cholesterol and the number of cardiovascular risk factors, considering SLE as an additional risk factor. For secondary prevention, experts have agreed on an LDL-cholesterol target of <0.7 g/L. Hypertension should be managed according to the 2013 European guidelines, using renin-angiotensin system blockers as first line agents in case of renal involvement. Aspirin can be prescribed in patients with high cardiovascular risk or with antiphospholipid antibodies.
These recommendations about the screening and management of cardiovascular risk factors in SLE can be expected to improve clinical practice uniformity and, in the longer term, to optimize the management of SLE patients.</description><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Evidence-Based Medicine</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Mass Screening - methods</subject><subject>Risk Factors</subject><subject>Secondary Prevention</subject><issn>1768-3122</issn><issn>1768-3122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUctOHDEQtKJEsCH8AUJ9zGU39tjz4oZWgURCQgpwXrU9PRvDjD3YnlX2k_jLOLCROHWru6pU1c3YmeArwUX17XEVaDdStyq4UHm04rz9wBairpqlFEXx8V1_zD7H-Mg5z8z2iB0XpSrLtlQL9nJnApGzbgvoOhjR4ZZGcgl8DwZDZ_0Oo5kHDBBsfIIeTfIhgnUQ9zHRaA0M8zRHoLBPv2nE5OMcL-AXGT9mpQ6T9S5C7wOYwTprcIApZBlrCDRG6sA7yFQYbKKAaQ70aob-TBSykSmTvPvCPvU4RDo91BP2cPX9fv1jeXN7_XN9ebOchBJpqRtUBvsqRyfdm1IUWteqboqibTqNupEdGVG3NXEt6r4xFaJSQv5byI4recK-vulOwT_PFNNmtNHQMKAjP8eNqBopS1lWbYaeH6Czzp_YTMGOGPab_-eVfwGbfoQY</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Arnaud, L</creator><creator>Mathian, A</creator><creator>Adoue, D</creator><creator>Bader-Meunier, B</creator><creator>Baudouin, V</creator><creator>Belizna, C</creator><creator>Bonnotte, B</creator><creator>Boumedine, F</creator><creator>Chaib, A</creator><creator>Chauchard, M</creator><creator>Chiche, L</creator><creator>Daugas, E</creator><creator>Ghali, A</creator><creator>Gobert, P</creator><creator>Gondran, G</creator><creator>Guettrot-Imbert, G</creator><creator>Hachulla, E</creator><creator>Hamidou, M</creator><creator>Haroche, J</creator><creator>Hervier, B</creator><creator>Hummel, A</creator><creator>Jourde-Chiche, N</creator><creator>Korganow, A-S</creator><creator>Kwon, T</creator><creator>Le Guern, V</creator><creator>Le Quellec, A</creator><creator>Limal, N</creator><creator>Magy-Bertrand, N</creator><creator>Marianetti-Guingel, P</creator><creator>Martin, T</creator><creator>Martin Silva, N</creator><creator>Meyer, O</creator><creator>Miyara, M</creator><creator>Morell-Dubois, S</creator><creator>Ninet, J</creator><creator>Papo, T</creator><creator>Pennaforte, J-L</creator><creator>Polomat, K</creator><creator>Pourrat, J</creator><creator>Queyrel, V</creator><creator>Raymond, I</creator><creator>Remy, P</creator><creator>Sacre, K</creator><creator>Schmidt, J</creator><creator>Sibilia, J</creator><creator>Viallard, J-F</creator><creator>Viau Brabant, A</creator><creator>Wahl, D</creator><creator>Bruckert, E</creator><creator>Amoura, Z</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion</title><author>Arnaud, L ; Mathian, A ; Adoue, D ; Bader-Meunier, B ; Baudouin, V ; Belizna, C ; Bonnotte, B ; Boumedine, F ; Chaib, A ; Chauchard, M ; Chiche, L ; Daugas, E ; Ghali, A ; Gobert, P ; Gondran, G ; Guettrot-Imbert, G ; Hachulla, E ; Hamidou, M ; Haroche, J ; Hervier, B ; Hummel, A ; Jourde-Chiche, N ; Korganow, A-S ; Kwon, T ; Le Guern, V ; Le Quellec, A ; Limal, N ; Magy-Bertrand, N ; Marianetti-Guingel, P ; Martin, T ; Martin Silva, N ; Meyer, O ; Miyara, M ; Morell-Dubois, S ; Ninet, J ; Papo, T ; Pennaforte, J-L ; Polomat, K ; Pourrat, J ; Queyrel, V ; Raymond, I ; Remy, P ; Sacre, K ; Schmidt, J ; Sibilia, J ; Viallard, J-F ; Viau Brabant, A ; Wahl, D ; Bruckert, E ; Amoura, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-b8a4caf6768ebfc512bb74782298dbab83dec1797e0b17f8c6aa4413b83d3d043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2015</creationdate><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Evidence-Based Medicine</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Mass Screening - methods</topic><topic>Risk Factors</topic><topic>Secondary Prevention</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arnaud, L</creatorcontrib><creatorcontrib>Mathian, A</creatorcontrib><creatorcontrib>Adoue, D</creatorcontrib><creatorcontrib>Bader-Meunier, B</creatorcontrib><creatorcontrib>Baudouin, V</creatorcontrib><creatorcontrib>Belizna, C</creatorcontrib><creatorcontrib>Bonnotte, B</creatorcontrib><creatorcontrib>Boumedine, F</creatorcontrib><creatorcontrib>Chaib, A</creatorcontrib><creatorcontrib>Chauchard, M</creatorcontrib><creatorcontrib>Chiche, L</creatorcontrib><creatorcontrib>Daugas, E</creatorcontrib><creatorcontrib>Ghali, A</creatorcontrib><creatorcontrib>Gobert, P</creatorcontrib><creatorcontrib>Gondran, G</creatorcontrib><creatorcontrib>Guettrot-Imbert, G</creatorcontrib><creatorcontrib>Hachulla, E</creatorcontrib><creatorcontrib>Hamidou, M</creatorcontrib><creatorcontrib>Haroche, J</creatorcontrib><creatorcontrib>Hervier, B</creatorcontrib><creatorcontrib>Hummel, A</creatorcontrib><creatorcontrib>Jourde-Chiche, N</creatorcontrib><creatorcontrib>Korganow, A-S</creatorcontrib><creatorcontrib>Kwon, T</creatorcontrib><creatorcontrib>Le Guern, V</creatorcontrib><creatorcontrib>Le Quellec, A</creatorcontrib><creatorcontrib>Limal, N</creatorcontrib><creatorcontrib>Magy-Bertrand, N</creatorcontrib><creatorcontrib>Marianetti-Guingel, P</creatorcontrib><creatorcontrib>Martin, T</creatorcontrib><creatorcontrib>Martin Silva, N</creatorcontrib><creatorcontrib>Meyer, O</creatorcontrib><creatorcontrib>Miyara, M</creatorcontrib><creatorcontrib>Morell-Dubois, S</creatorcontrib><creatorcontrib>Ninet, J</creatorcontrib><creatorcontrib>Papo, T</creatorcontrib><creatorcontrib>Pennaforte, J-L</creatorcontrib><creatorcontrib>Polomat, K</creatorcontrib><creatorcontrib>Pourrat, J</creatorcontrib><creatorcontrib>Queyrel, V</creatorcontrib><creatorcontrib>Raymond, I</creatorcontrib><creatorcontrib>Remy, P</creatorcontrib><creatorcontrib>Sacre, K</creatorcontrib><creatorcontrib>Schmidt, J</creatorcontrib><creatorcontrib>Sibilia, J</creatorcontrib><creatorcontrib>Viallard, J-F</creatorcontrib><creatorcontrib>Viau Brabant, A</creatorcontrib><creatorcontrib>Wahl, D</creatorcontrib><creatorcontrib>Bruckert, E</creatorcontrib><creatorcontrib>Amoura, Z</creatorcontrib><creatorcontrib>groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arnaud, L</au><au>Mathian, A</au><au>Adoue, D</au><au>Bader-Meunier, B</au><au>Baudouin, V</au><au>Belizna, C</au><au>Bonnotte, B</au><au>Boumedine, F</au><au>Chaib, A</au><au>Chauchard, M</au><au>Chiche, L</au><au>Daugas, E</au><au>Ghali, A</au><au>Gobert, P</au><au>Gondran, G</au><au>Guettrot-Imbert, G</au><au>Hachulla, E</au><au>Hamidou, M</au><au>Haroche, J</au><au>Hervier, B</au><au>Hummel, A</au><au>Jourde-Chiche, N</au><au>Korganow, A-S</au><au>Kwon, T</au><au>Le Guern, V</au><au>Le Quellec, A</au><au>Limal, N</au><au>Magy-Bertrand, N</au><au>Marianetti-Guingel, P</au><au>Martin, T</au><au>Martin Silva, N</au><au>Meyer, O</au><au>Miyara, M</au><au>Morell-Dubois, S</au><au>Ninet, J</au><au>Papo, T</au><au>Pennaforte, J-L</au><au>Polomat, K</au><au>Pourrat, J</au><au>Queyrel, V</au><au>Raymond, I</au><au>Remy, P</au><au>Sacre, K</au><au>Schmidt, J</au><au>Sibilia, J</au><au>Viallard, J-F</au><au>Viau Brabant, A</au><au>Wahl, D</au><au>Bruckert, E</au><au>Amoura, Z</au><aucorp>groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2015-06</date><risdate>2015</risdate><volume>36</volume><issue>6</issue><spage>372</spage><pages>372-</pages><issn>1768-3122</issn><eissn>1768-3122</eissn><abstract>To develop French recommendations about screening and management of cardiovascular risk factors in systemic lupus erythematosus (SLE).
Thirty-nine experts qualified in internal medicine, rheumatology and nephrology have selected recommendations from a list developed based on evidence from the literature. For each recommendation, the level of evidence and the level of agreement among the experts were specified.
Experts recommended an annual screening of cardiovascular risk factors in SLE. Statins should be prescribed for primary prevention in SLE patients based on the level of LDL-cholesterol and the number of cardiovascular risk factors, considering SLE as an additional risk factor. For secondary prevention, experts have agreed on an LDL-cholesterol target of <0.7 g/L. Hypertension should be managed according to the 2013 European guidelines, using renin-angiotensin system blockers as first line agents in case of renal involvement. Aspirin can be prescribed in patients with high cardiovascular risk or with antiphospholipid antibodies.
These recommendations about the screening and management of cardiovascular risk factors in SLE can be expected to improve clinical practice uniformity and, in the longer term, to optimize the management of SLE patients.</abstract><cop>France</cop><pmid>25455954</pmid><doi>10.1016/j.revmed.2014.10.009</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1768-3122 |
| ispartof | La revue de medecine interne, 2015-06, Vol.36 (6), p.372 |
| issn | 1768-3122 1768-3122 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_1683353569 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Cardiovascular Diseases - diagnosis Cardiovascular Diseases - drug therapy Cardiovascular Diseases - etiology Evidence-Based Medicine Guidelines as Topic Humans Lupus Erythematosus, Systemic - complications Mass Screening - methods Risk Factors Secondary Prevention |
| title | Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A53%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20and%20management%20of%20cardiovascular%20risk%20factors%20in%20systemic%20lupus%20erythematosus:%20Recommendations%20for%20clinical%20practice%20based%20on%20the%20literature%20and%20expert%20opinion&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Arnaud,%20L&rft.aucorp=groupe%20France%20Lupus%20%C3%89ryth%C3%A9mateux%20syst%C3%A9mique%20R%C3%A9seau%20(FLEUR)%20et%20les%20centres%20de%20r%C3%A9f%C3%A9rence%20et%20de%20comp%C3%A9tence%20des%20lupus%20et%20syndromes%20des%20antiphospholipides&rft.date=2015-06&rft.volume=36&rft.issue=6&rft.spage=372&rft.pages=372-&rft.issn=1768-3122&rft.eissn=1768-3122&rft_id=info:doi/10.1016/j.revmed.2014.10.009&rft_dat=%3Cproquest_pubme%3E1683353569%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1683353569&rft_id=info:pmid/25455954&rfr_iscdi=true |